JPMorgan Downgrades Endologix (ELGX) to Neutral
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
JPMorgan downgraded Endologix (NASDAQ: ELGX) from Overweight to Neutral with a price target of $10.00 (from $14.00).
Shares of Endologix closed at $9.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades NetApp (NTAP) to Underperform
- Wedbush Raises Price Target on Francesca's (FRAN) Following 3Q Report
- JPMorgan Downgrades Virgin America (VA) to Underweight
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!